Search Orphan Drug Designations and Approvals
-
Generic Name: | Autologous delta-like-ligand 3 (DLL3)-targeted chimeric antigen receptor (CAR) T-cells |
---|---|
Date Designated: | 06/21/2023 |
Orphan Designation: | Treatment of small cell lung cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Legend Biotech USA, Inc. 2101 Cottontail Lane Somerset, New Jersey 08873 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-